Free tool
FAERS Monitor: Tigecycline
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208744 or its brand name (Tigecycline, Tigecycline). Reports on generic versions are filed under their own applications.
Reports
4,358
Serious
4,073
93% of reports
Hospitalization
1,833
Death reported
1,192
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective638
- off label use549
- nausea302
- drug resistance213
- sepsis207
- vomiting205
- septic shock193
- thrombocytopenia193
- pathogen resistance172
- product use in unapproved indication168
- diarrhoea156
- acute kidney injury153
- condition aggravated153
- death147
- treatment failure139
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 2 |
| 2006 | 8 |
| 2007 | 31 |
| 2008 | 63 |
| 2009 | 50 |
| 2010 | 37 |
| 2011 | 61 |
| 2012 | 71 |
| 2013 | 80 |
| 2014 | 79 |
| 2015 | 151 |
| 2016 | 107 |
| 2017 | 216 |
| 2018 | 241 |
| 2019 | 404 |
| 2020 | 360 |
| 2021 | 419 |
| 2022 | 332 |
| 2023 | 417 |
| 2024 | 518 |
| 2025 | 413 |
| 2026 | 298 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,801 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pathogen resistanceSignal | 172 | 92.8 | 80.0 | 15,242 |
| drug resistanceSignal | 213 | 40.3 | 35.4 | 8,076 |
| septic shockSignal | 193 | 21.5 | 18.7 | 3,743 |
| sepsisSignal | 207 | 9.0 | 7.9 | 1,463 |
| thrombocytopeniaSignal | 193 | 8.3 | 7.3 | 1,244 |
| treatment failureSignal | 139 | 8.1 | 6.9 | 861 |
| acute kidney injurySignal | 153 | 4.8 | 4.1 | 464 |
| product use in unapproved indicationSignal | 168 | 3.3 | 2.8 | 266 |
| off label useSignal | 549 | 3.0 | 2.8 | 775 |
| condition aggravatedSignal | 153 | 2.4 | 2.1 | 129 |
| drug ineffectiveSignal | 638 | 2.3 | 2.2 | 519 |
| vomitingSignal | 205 | 2.1 | 1.8 | 120 |
| nausea | 302 | 1.8 | 1.7 | 120 |
| diarrhoea | 156 | 1.2 | 1.0 | 4 |
| death | 147 | 0.8 | 0.7 | 6 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.